Patents by Inventor Kuo-Sheng Hung

Kuo-Sheng Hung has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Use of indolyl and indolinyl hydroxamates for treating neurodegenerative disorders or cognitive decicits
    Patent number: 9956202
    Abstract: The present invention relates to novel use of indolyl and indolinyl hydroxamates. Particularly, the invention relates to use of indolyl and indolinyl hydroxamates in the manufacturing a medicament or a pharmaceutical composition for treating a ischemic and hemorrhagic stroke, spinal cord injury, cranial nerve injury, peripheral nerve injury and a neurodegenerative disorder or cognitive deficit.
    Type: Grant
    Filed: November 24, 2014
    Date of Patent: May 1, 2018
    Assignee: Taipei Medical University
    Inventor: Kuo Sheng Hung
  • Indolyl or indolinyl hydroxamate compounds
    Patent number: 9598364
    Abstract: Indolyl or indolinyl compounds of formula (I): wherein bond, n, R1, R2, R3, R4, R5, and R6, are defined herein. Also disclosed is a method for treating cancer with these compounds.
    Type: Grant
    Filed: August 26, 2014
    Date of Patent: March 21, 2017
    Assignees: Taipei Medical University, Ohio State University, National Taiwan University
    Inventors: Ching-Shih Chen, Jing-Ping Liou, Hsing-Jin Liu, Kuo-Sheng Hung, Pei-Wen Shan, Wen-Ta Chiu, Che-Ming Teng
  • USE OF INDOLYL AND IDOLINYL HYDROXAMATES FOR TREATING NEURODEGENERATIVE DISORDERS OR COGNITIVE DECICITS
    Publication number: 20160303079
    Abstract: The present invention relates to novel use of indolyl and indolinyl hydroxamates. Particularly, the invention relates to use of indolyl and indolinyl hydroxamates in the manufacturing a medicament or a pharmaceutical composition for treating a ischemic and hemorrhagic stroke, spinal cord injury, cranial nerve injury, peripheral nerve injury and a neurodegenerative disorder or cognitive deficit.
    Type: Application
    Filed: November 24, 2014
    Publication date: October 20, 2016
    Inventor: Kuo Sheng HUNG
  • Use of indolyl and indolinyl hydroxamates for treating heart failure of neuronal injury
    Patent number: 9296692
    Abstract: Novel use of small molecules, particularly indolyl and indolinyl hydroxamates is disclosed herein. The indolyl and indolinyl hydroxamates are useful as lead compounds for manufacturing a medicament or a pharmaceutical composition for treating a patient suffering from heart failure or neuronal injury.
    Type: Grant
    Filed: September 15, 2012
    Date of Patent: March 29, 2016
    Assignee: TAIPEI MEDICAL UNIVERSITY
    Inventors: Yi-Jen Chen, Kuo-Sheng Hung, Yu-Hsun Kao, Jing-Ping Liou, Pei-Wen Shan
  • Use of Indolyl and Indolinyl Hydroxamates for Treating Heart Failure of Neuronal Injury
    Publication number: 20150065552
    Abstract: Novel use of small molecules, particularly indolyl and indolinyl hydroxamates is disclosed herein. The indolyl and indolinyl hydroxamates are useful as lead compounds for manufacturing a medicament or a pharmaceutical composition for treating a patient suffering from heart failure or neuronal injury.
    Type: Application
    Filed: September 15, 2012
    Publication date: March 5, 2015
    Applicant: Taipei Medical University
    Inventors: Yi-Jen Chen, Kuo-Sheng Hung, Yu-Hsun Kao, Jing-Ping Liou, Pei-Wen Shan
  • INDOLYL OR INDOLINYL HYDROXAMATE COMPOUNDS
    Publication number: 20140364477
    Abstract: Indolyl or indolinyl compounds of formula (I): wherein bond, n, R1, R2, R3, R4, R5, and R6, are defined herein. Also disclosed is a method for treating cancer with these compounds.
    Type: Application
    Filed: August 26, 2014
    Publication date: December 11, 2014
    Applicants: Ohio State University, National Taiwan University
    Inventors: Ching-Shih Chen, Jing-Ping Liou, Hsing-Jin Liu, Kuo-Sheng Hung, Pei-Wen Shan, Wen-Ta Chiu, Che-Ming Teng
  • Indolyl or indolinyl hydroxamate compounds
    Patent number: 8846748
    Abstract: Indolyl or indolinyl compounds of formula (I): wherein bond, n, R1, R2, R3, R4, R5, and R6, are defined herein. Also disclosed is a method for treating cancer with these compounds.
    Type: Grant
    Filed: March 29, 2011
    Date of Patent: September 30, 2014
    Assignees: Taipei Medical University, Ohio State University, National Taiwan University
    Inventors: Ching-Shih Chen, Jing-Ping Liou, Hsing-Jin Liu, Kuo-Sheng Hung, Pei-Wen Shan, Wen-Ta Chiu, Che-Ming Teng
  • Isolated transgenic mammalian neural cell for detection of a sample containing a chemical substance damage to neurological system or selection of drugs for treating neurodegenerative disorders
    Patent number: 8211695
    Abstract: The invention is to provide an isolated transgenic mammalian neural cell, which comprises at least one heterologous vector expressing AhR/ARNT. Also provided is methods the detection of a sample containing a chemical substance damage to the nervous system and the selection of drugs for treating neurodegenerative disorders.
    Type: Grant
    Filed: March 31, 2010
    Date of Patent: July 3, 2012
    Assignee: Taipei Medical University
    Inventors: Yi-Hsuan Lee, Cheng-Yu Wang, Shu-Hui Juan, Wen-Liang Chen, Kuo-Sheng Hung, Chun-Hua Lin
  • INDOLYL OR INDOLINYL HYDROXAMATE COMPOUNDS
    Publication number: 20110245315
    Abstract: Indolyl or indolinyl compounds of formula (I): wherein bond, n, R1, R2, R3, R4, R5, and R6, are defined herein. Also disclosed is a method for treating cancer with these compounds.
    Type: Application
    Filed: March 29, 2011
    Publication date: October 6, 2011
    Applicants: Taipei Medical University, Ohio State University, National Taiwan University
    Inventors: Ching-Shih Chen, Jing-Ping Liou, Hsing-Jin Liu, Kuo-Sheng Hung, Pei-Wen Shan, Wen-Ta Chiu, Che-Ming Teng
  • ISOLATED TRANSGENIC MAMMALIAN NEURAL CELL FOR DETECTION OF A SAMPLE CONTAINING A CHEMICAL SUBSTANCE DAMAGE TO NEUROLOGICAL SYSTEM OR SELECTION OF DRUGS FOR TREATING NEURODEGENERATIVE DISORDERS
    Publication number: 20110244470
    Abstract: The invention is to provide an isolated transgenic mammalian neural cell, which comprises at least one heterologous vector expressing AhR/ARNT. Also provided is methods the detection of a sample containing a chemical substance damage to the nervous system and the selection of drugs for treating neurodegenerative disorders.
    Type: Application
    Filed: March 31, 2010
    Publication date: October 6, 2011
    Applicant: TAIPEI MEDICAL UNIVERSITY
    Inventors: Yi-Hsuan Lee, Cheng-Yu Wang, Shu-Hui Juan, Wen-Liang Chen, Kuo-Sheng Hung, Chun-Hua Lin
  • Packing bag having a drawing structure
    Publication number: 20080175522
    Abstract: A packing bag having a drawing structure comprises a bag housing and a drawn slice. The bag housing has an opening on one side thereof for placing a product conveniently into the bag housing through the opening. The drawing piece is connected on a side of the bag housing. Thereby, it is easy for customers to extract the products placed in pallets as long as equal force is applied to extract upwardly the drawing piece of the packing bags without damaging the products.
    Type: Application
    Filed: January 18, 2007
    Publication date: July 24, 2008
    Inventors: Chin-Hsin Chuang, Yu-Chuan Lin, Kuo-Sheng Hung, Ping-Yang Chen